Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Invesco Ltd. (IVZ) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the stock trades at a forward P/E of 10.14 and offers a 3.2% dividend yield, the significant increase in debt leverage and persistent earnings instability warrant a cautious approach.
Invesco Ltd. (IVZ) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Invesco Ltd. (IVZ) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 28, 2026 | $0.57vs $0.58-1.2% | $1.3Bvs $1.3B-0.3% |
| Q1 2026 | Jan 27, 2026 | $0.62vs $0.58+6.9% | $1.3Bvs $1.3B+0.4% |
| Q4 2025 | Oct 28, 2025 | $0.61vs $0.45+36.1% | $1.6Bvs $1.2B+39.5% |
| Q3 2025 | Jul 22, 2025 | $0.36vs $0.41-12.2% | $1.5Bvs $1.2B+29.4% |
Recent stock market news and headlines for Invesco Ltd. (IVZ)
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DUBLIN--(BUSINESS WIRE)--Northern Trust (Nasdaq: NTRS) today announced it has been appointed by Invesco to provide administration, custody and depositary services for its new Irish-domiciled index tracking mutual fund range, Invesco Markets V ICAV. Invesco is a U.S. asset management company serving clients in more than 120 countries. Headquartered in Atlanta, Georgia, the firm has US$2.45 trillion in assets under management across public, private, active, and passive investments (as of 31 May 2.
State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio and far greater assets under management than Invesco Pharmaceuticals ETF. Invesco's ETF focuses exclusively on 29 pharmaceutical companies, whereas the SPDR fund provides broader exposure across the healthcare sector.
Vanguard S&P 500 Growth ETF offers a significantly lower expense ratio than Invesco S&P SmallCap 600 Revenue ETF. Invesco's ETF has delivered higher one-year total returns but lower five-year growth than the Vanguard fund.
Invesco's Fiona Lim says the AI-fueled semiconductor surge is shifting from a broad, momentum-driven rally to a tougher phase where stock picking and profitability will separate winners from laggards.
Key metrics vs top competitors for Invesco Ltd. (IVZ)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $27.40 | $12.17B | -17.13 | 5.11% | -4.42% | -1.96% | 3.03% | |
| $34.36 | $17.85B | 37.76 | 3.45% | 8.99% | 5.64% | — | |
| $120.16 | $26.15B | 12.99 | 3.12% | 28.28% | 17.56% | — | |
| $359.72 | $9.5B | 15.82 | 19.83% | 31.89% | 17.07% | — | |
| $155.15 | $1.04B | 7.77 | -8% | 14.61% | 11.15% | — | |
| $174.99 | $473.29M | 9.77 | 4.48% | 30.89% | 27.03% | — |
Invesco Ltd. (IVZ) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Invesco Ltd. (IVZ) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 28, 2026·SEC
Apr 10, 2026·SEC
Mar 10, 2026·SEC
Feb 24, 2026·SEC
Get notified when IVZ posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Invesco Ltd. (IVZ) stock FAQ — growth, dividends, profitability & financials explained
Invesco Ltd. (IVZ) reported $6.59B in revenue for fiscal year 2025.
Invesco Ltd. (IVZ) grew revenue by 5.1% over the past year. This is steady growth.
Invesco Ltd. (IVZ) reported a net loss of $243.4M for fiscal year 2025.
Yes, Invesco Ltd. (IVZ) pays a dividend with a yield of 3.03%. This makes it attractive for income-focused investors.
Invesco Ltd. (IVZ) has a return on equity (ROE) of -2.0%. Negative ROE indicates the company is unprofitable.
Invesco Ltd. (IVZ) generated $1.88B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.